Results 151 to 160 of about 13,334 (226)
Some of the next articles are maybe not open access.
Tricyclic quinuclidylidenes as potential antihistamine-bronchodilating agents
Journal of Medicinal Chemistry, 1975F J, Villani, T A, Mann, E A, Wefer
openaire +2 more sources
Molecular imaging in oncology: Current impact and future directions
Ca-A Cancer Journal for Clinicians, 2022Steven P Rowe, Martin G Pomper
exaly
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly
[Measurement of the effect of a bronchodilator agent].
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1990Response in a bronchodilator must be expressed by the combining the largest amplitude of response with the highest reproducibility. The forced expiratory volume in the first second (FEV1) meets these conditions and thus represents the best test. The bronchodilator response is commonly expressed in percent of the initial FEV1.
openaire +1 more source
SC-10049: A CATECHOLAMINE BRONCHODILATOR AND HYPERGLYCEMIC AGENT
The Journal of Pharmacology and Experimental Therapeutics, 1961C G, VAN ARMAN +2 more
openaire +2 more sources
Recent progress in the treatment of cancer in children
Ca-A Cancer Journal for Clinicians, 2021Theodore W Laetsch
exaly
, 1992